Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer von van Soest, R.J, van Royen, M.E, de Morrée, E.S, Moll, J.M, Teubel, W, Wiemer, E.A.C, Mathijssen, R.H.J, de Wit, R, van Weerden, W.M

Volltext

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs von van Leeuwen, R W F, Brundel, D H S, Neef, C, van Gelder, T, Mathijssen, R H J, Burger, D M, Jansman, F G A

Volltext

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells von van Jaarsveld, M T M, Helleman, J, Boersma, A W M, van Kuijk, P F, van IJcken, W F, Despierre, E, Vergote, I, Mathijssen, R H J, Berns, E M J J, Verweij, J, Pothof, J, Wiemer, E A C

Volltext

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab von Heine, R J S D, Thielen, F W, Mathijssen, R H J, van Leeuwen, R W F, Franken, M G, Uyl-de Groot, C A

Volltext

Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity von Filipski, K K, Mathijssen, R H, Mikkelsen, T S, Schinkel, A H, Sparreboom, A

Volltext

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer von van Soest, R.J, Nieuweboer, A.J.M, de Morrée, E.S, Chitu, D, Bergman, A.M, Goey, S.H, Bos, M.M, van der Meer, N, Hamberg, P, de Wit, R, Mathijssen, R.H.J

Volltext

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study von Groenland, S.L., van Eerden, R.A.G., Westerdijk, K., Meertens, M., Koolen, S.L.W., Moes, D.J.A.R., de Vries, N., Rosing, H., Otten, H., Vulink, A.J.E., Desar, I.M.E., Imholz, A.L.T., Gelderblom, H., van Erp, N.P., Beijnen, J.H., Mathijssen, R.H.J., Huitema, A.D.R., Steeghs, N.

Volltext

Pemetrexed exposure predicts toxicity in advanced non–small-cell lung cancer: A prospective cohort study von Visser, S., Koolen, S.L.W., de Bruijn, P., Belderbos, H.N.A., Cornelissen, R., Mathijssen, R.H.J., Stricker, B.H., Aerts, J.G.J.V.

Volltext

Drug–drug interactions in patients treated for cancer: a prospective study on clinical interventions von van Leeuwen, R.W.F., Jansman, F.G.A., van den Bemt, P.M.L.A., de Man, F., Piran, F., Vincenten, I., Jager, A., Rijneveld, A.W., Brugma, J.D., Mathijssen, R.H.J., van Gelder, T.

Volltext

Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro–in vivo correlations von Hu, S, Mathijssen, R H J, de Bruijn, P, Baker, S D, Sparreboom, A

Volltext

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662 von Diekstra, M H M, Klümpen, H J, Lolkema, M P J K, Yu, H, Kloth, J S L, Gelderblom, H, van Schaik, R H N, Gurney, H, Swen, J J, Huitema, A D R, Steeghs, N, Mathijssen, R H J

Volltext

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling von Verheijen, R.B., Thijssen, B., Atrafi, F., Schellens, J.H.M., Rosing, H., de Vries, N., Beijnen, J.H., Mathijssen, R.H.J., Steeghs, N., Huitema, A.D.R.

Volltext

The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies von de Joode, K., van de Geer, W. S., van Leenders, G. J. L. H., Hamberg, P., Westgeest, H. M., Beeker, A., Oosting, S. F., van Rooijen, J. M., Beerepoot, L. V., Labots, M., Mathijssen, R. H. J., Lolkema, M. P., Cuppen, E., Sleijfer, S., van de Werken, H. J. G., van der Veldt, A. A. M.

Volltext

Novel treatment options in the management of metastatic castration-naïve prostate cancer; which treatment modality to choose? von Belderbos, B.P.S., de Wit, R., Lolkema, M.P.J., Mathijssen, R.H.J., van Soest, R.J.

Volltext

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours von Lankheet, N A G, Kloth, J S L, Gadellaa-van Hooijdonk, C G M, Cirkel, G A, Mathijssen, R H J, Lolkema, M P J K, Schellens, J H M, Voest, E E, Sleijfer, S, de Jonge, M J A, Haanen, J B A G, Beijnen, J H, Huitema, A D R, Steeghs, N

Volltext

Conventional Dosing of Anticancer Agents: Precisely Wrong or Just Inaccurate? von Bins, S, Ratain, M J, Mathijssen, R H J

Volltext

Conjunctive Therapy of Cisplatin With the OCT2 Inhibitor Cimetidine: Influence on Antitumor Efficacy and Systemic Clearance von Sprowl, J A, van Doorn, L, Hu, S, van Gerven, L, de Bruijn, P, Li, L, Gibson, A A, Mathijssen, R H, Sparreboom, A

Volltext

Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors von Kloth, J S L, Pagani, A, Verboom, M C, Malovini, A, Napolitano, C, Kruit, W H J, Sleijfer, S, Steeghs, N, Zambelli, A, Mathijssen, R H J

Volltext

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours von Gits, C M M, van Kuijk, P F, Jonkers, M B E, Boersma, A W M, van IJcken, W F, Wozniak, A, Sciot, R, Rutkowski, P, Schöffski, P, Taguchi, T, Mathijssen, R H J, Verweij, J, Sleijfer, S, Debiec-Rychter, M, Wiemer, E A C

Volltext

Bioturbation by Benthic Stingrays Alters the Biogeomorphology of Tidal Flats von Nauta, Janne, Leurs, Guido, Nieuwenhuis, Brian O., Mathijssen, Donné R. A. H., Olff, Han, Bouma, Tjeerd J., van der Wal, Daphne, Hijner, Nadia, Regalla, Aissa, Pontes, Samuel Ledo, Govers, Laura L.

Volltext